Case 52Transformative Acquisition Underwriting And IntegrationFailure
HP–Autonomy acquisition diligence and impairment failure
Hewlett-Packard Company / Autonomy Corporation plc · 2011–2025
As a simulated public-evidence public-equity underwriting committee one second after SEC acceptance of HP's signed Autonomy offer, should an adviser add or retain HP exposure, and what acquisition-diligence and integration risks should it monitor, when complete valuation, capitalization, signing-date liquidity, target interim cash-flow, and integration-cost inputs remain unavailable?
HP public-equity review after the signed Autonomy offer
Decision time
August 19, 2011
Knowledge cutoff
August 19, 2011
Recommended path
The cutoff record supports disciplined acquisition-risk monitoring but no public-equity direction. Abstain from add, retain, reduce, exit, target-price, and position-sizing advice; monitor whether HP preserves the announced separate-group accountability and clears the accounting, customer, contribution, control, liquidity, and leadership-capacity gates. Any actual portfolio action remains human-governed and requires complete point-in-time underwriting.
Confidence
Moderate
What happened
HP proceeded with the Autonomy acquisition and later reported approximately USD 11.0 billion acquisition-date fair-value consideration, followed in FY2012 by an USD 8.8 billion non-cash goodwill and purchased-intangible impairment. The record does not establish that HP used the Part A monitoring gates or support a standalone acquisition IRR or shareholder return.
Part A's refusal to convert a strategic thesis into exposure advice was well calibrated because capitalization, market price, pro-forma liquidity, interim target cash flow, reporting detail, and integration costs were incomplete. Its accounting and management-capacity gates identified risks that later evidence makes important to study, but the public outcome record does not prove HP adopted those gates or that the contemporaneous bandwidth warning became a realized cause.
Separate public-equity exposure from acquisition-governance advice. Abstain from target price, position size, add, retain, reduce, or exit conclusions until complete valuation, capitalization, cash-flow, and conflict inputs are source-linked and human approved. For monitoring, request public or authoritatively supplied evidence of a ring-fenced target ledger, accountable operating core, contract quality, revenue, receivables, deferred revenue, and cash. Treat issuer-side integration waves as underwritten only after customer health, incremental cash contribution, control readiness, liquidity, and leadership-capacity benchmarks pass for two consecutive quarterly reviews. If evidence remains unavailable or material benchmarks fail through four quarterly reviews, continue exposure abstention and require fresh human-owned public-equity underwriting. Any operational pause or release remains an issuer decision.
High prices amplify errors in reported economics and synergy forecasts, while simultaneous transformation can slow decisions and remediation. Stable ledgers, independent accounting tests, explicit accountable owners, reversible integration waves, and precommitted cash gates prevent strategic narrative, adjusted metrics, and impairment hindsight from replacing evidence.